In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a ...

No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

No. 2 / 2025Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant clinical ...

Our definition of these non-GAAP financial measures is not necessarily ... including our implementation thereof; the impact of glucagon-like peptide 1 class of drugs on demand for our Inspire therapy; ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment. While diabetes is a known risk factor, the role of elevated glucose levels ...

In severe instances, when large doses of insulin are administered, or there is a delay in treating low blood sugar, hypoglycemia can cause rare symptoms, such as: The definition of an overdose is ...

With today’s sweetener market evolving rapidly, experts highlight how natural sweetener solutions are helping beverage-makers ...

When starting a weight loss journey, one of the first things you might think about is how to build a balanced, nutritious diet to set yourself up for success.

The team also found that the mouse neurons could be activated by a compound called a glucagon-like peptide-1 (GLP-1) agonist, a type of drug used to treat obesity and type 2 diabetes, the most ...